List of insiders holdings for Innoviva Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| DENNER ALEXANDER J Sarissa Capital Management LP 10% Owner | 2023-06-20 21:00:25 | 0 7,277,000 | 7,277,000 | Form 4 |
| Raifeld Pavel Chief Executive Officer | 2024-03-07 18:57:57 | 2,086,666 0 | 2,086,666 | Form 4 |
| MULLEN MICHAEL Director | 2004-10-04 14:18:20 | 25,806 2,007,168 | 2,032,974 | Form 3 |
| VAGELOS P ROY Director | 2009-12-23 18:44:17 | 559,640 1,167,927 | 1,727,567 | Form 4 |
| Aguiar Michael W President & Chief Exec Officer | 2017-12-05 17:17:09 | 980,907 0 | 980,907 | Form 4 |
| Winningham Rick E Director | 2014-08-19 19:07:09 | 825,391 0 | 825,391 | Form 4 |
| WHITESIDES GEORGE M Director | 2014-05-27 19:15:11 | 612,377 170,318 | 782,695 | Form 4 |
| Shafer Bradford J Sr VP, Gen. Counsel, Secretary | 2014-08-22 17:01:54 | 443,013 0 | 443,013 | Form 4 |
| Kitt Michael Sr. Vice President Development | 2008-06-04 19:01:30 | 423,255 2000 | 425,255 | Form 4 |
| BLUM LEONARD M Sr VP, Chief Comm. Officer | 2014-08-22 17:00:26 | 401,538 0 | 401,538 | Form 4 |
| dEsparbes Eric SVP and CFO | 2018-05-22 19:53:23 | 373,081 0 | 373,081 | Form 4 |
| Mammen Mathai SVP, Research & Early Clin Dev | 2014-08-22 17:02:28 | 334,040 0 | 334,040 | Form 4 |
| GLICK MARTY Executive VP, Finance and CFO | 2004-10-07 15:35:53 | 267,805 32,258 | 300,063 | Form 4 |
| ABERCROMBIE GEORGE B Sr. VP & Chief Comm. Officer | 2018-08-22 18:46:58 | 285,479 0 | 285,479 | Form 4 |
| Faerm Michael E. Sr VP & Chief Business Officer | 2017-11-22 16:42:20 | 279,422 0 | 279,422 | Form 4 |
| LEE JUNNING Sr. VP, Technical Operations | 2014-08-22 17:03:04 | 262,198 0 | 262,198 | Form 4 |
| Witek Theodore J. Jr. Sr. VP & Chief Scientific Off. | 2018-08-22 18:43:11 | 247,767 0 | 247,767 | Form 4 |
| Basso Stephen Chief Financial Officer | 2024-03-07 19:04:15 | 187,995 0 | 187,995 | Form 4 |
| PASQUALONE FRANK Sr. Vice President, Operations | 2014-01-27 19:18:22 | 170,000 0 | 170,000 | Form 4 |
| JONKER JEFFREY DAVID Senior VP, Corp. & Bus. Dev. | 2013-10-24 19:08:21 | 165,000 0 | 165,000 | Form 4 |
| WALTRIP WILLIAM H Director | 2017-04-24 17:05:13 | 161,789 0 | 161,789 | Form 4 |
| Ronsheim Matthew See Remarks | 2024-03-07 19:02:35 | 161,216 0 | 161,216 | Form 4 |
| Bickerstaff George Director | 2022-04-27 18:52:15 | 147,207 0 | 147,207 | Form 4 |
| Haimovitz Jules Director | 2023-05-24 17:53:15 | 136,906 0 | 136,906 | Form 4 |
| Odysseas Kostas D Director | 2023-05-24 17:47:38 | 128,702 0 | 128,702 | Form 4 |
| Gunderson Robert V JR Director | 2014-05-27 19:11:34 | 121,970 5709 | 127,679 | Form 4 |
| DiPaolo Mark Director | 2023-05-24 17:50:55 | 124,706 0 | 124,706 | Form 4 |
| Schlesinger Sarah J. Director | 2023-05-24 17:54:29 | 124,706 0 | 124,706 | Form 4 |
| LEVINE ARNOLD J Director | 2014-03-25 19:39:02 | 111,794 0 | 111,794 | Form 4 |
| Zhen Marianne Chief Accounting Officer | 2024-03-07 19:00:22 | 110,588 0 | 110,588 | Form 4 |
| YOUNG WILLIAM D Director | 2014-05-27 19:16:04 | 89,935 0 | 89,935 | Form 4 |
| Humphrey Patrick PA Executive VP Research | 2007-12-10 19:57:20 | 74,954 11,000 | 85,954 | Form 4 |
| Birx Deborah Director | 2023-05-24 17:56:18 | 78,984 0 | 78,984 | Form 4 |
| PEPE PAUL Director | 2017-04-24 17:04:14 | 73,805 0 | 73,805 | Form 4 |
| FRIEDMAN CATHY Director | 2017-04-24 17:24:07 | 73,805 0 | 73,805 | Form 4 |
| Tyree James L Director | 2017-04-24 17:05:48 | 70,554 0 | 70,554 | Form 4 |
| Koziel Margaret Chief Medical Officer | 2023-08-02 21:32:54 | 60,000 0 | 60,000 | Form 4 |
| LEPORE PATRICK G Director | 2017-04-24 17:06:18 | 58,278 0 | 58,278 | Form 4 |
| Duncan Barbara Gayle Director | 2017-04-24 17:07:21 | 52,318 0 | 52,318 | Form 4 |
| HULME GEOFFREY Interim Principal Exec Officer | 2020-05-22 16:15:51 | 46,251 3500 | 49,751 | Form 4 |
| Brinkley David L Head of Business Dev. | 2013-05-31 19:02:23 | 48,749 0 | 48,749 | Form 4 |
| Loewenthal Ronn Director | 2006-05-04 15:28:30 | 47,226 0 | 47,226 | Form 4 |
| MALKIEL BURTON G Director | 2014-05-27 19:12:28 | 46,000 0 | 46,000 | Form 4 |
| Srivastava Sapna Director | 2023-05-24 17:57:46 | 42,673 0 | 42,673 | Form 4 |
| RINGROSE PETER S Director | 2014-05-27 19:13:12 | 42,000 0 | 42,000 | Form 4 |
| Fore Henrietta Director | 2014-05-27 19:10:39 | 39,000 0 | 39,000 | Form 4 |
| Kearney Terrence C Director | 2015-04-27 18:31:55 | 37,083 0 | 37,083 | Form 4 |
| DRAZAN JEFFREY M Director | 2012-05-02 19:01:40 | 33,465 0 | 33,465 | Form 4 |
| Slater Eve Elizabeth Director | 2007-04-27 20:47:49 | 15,000 0 | 15,000 | Form 4 |
| BAKER JULIAN Director | 2006-04-28 15:25:26 | 12,903 0 | 12,903 | Form 4 |
| Sturmer A Gregory Vice President Finance | 2005-02-14 15:06:59 | 8064 0 | 8064 | Form 4 |
| Campbell Arthur L Sr. VP, Technical Operations | 2008-01-31 19:07:24 | 5376 0 | 5376 | Form 4 |
| Edwards Larry G. CEO of La Jolla Pharmaceutical | 2022-08-26 09:17:06 | 0 0 | 0 | Form 3 |
| GLAXOSMITHKLINE PLC 10% Owner | 2021-05-25 16:24:54 | 0 0 | 0 | Form 13D |